CINCINNATI (WKRC) - A new study found that heavy drinkers are at higher risk of brain injury, specifically brain lesions. The postmortem study looked at over 1,700 people who died at around the age of ...

Andrew Pines, MD, MA, a resident in the Department of Psychiatry at Brigham and Women’s Hospital and a researcher in the Center for Brain Circuit Therapeutics, is the lead author of a paper published ...

Lesions that cause secondary psychosis were most functionally similar to lesions that cause amnesia, though lesions that cause amnesia were more likely to be in the brain’s left hemisphere while those ...

A new artificial intelligence tool that can detect tiny brain lesions that cause epilepsy in children could help speed up diagnoses, paving the way for a potential cure, experts revealed. Researchers ...

Recent arguments against drinking alcohol are getting louder. A new study published in the journal Neurology reveals that heavy drinking, aka having eight or more alcoholic drinks per week, can more ...

Regular heavy drinking could be doing more damage to your brain than simply clouding your memories of a wild night out — and what constitutes “heavy” drinking may be a lot less than you think. A new ...

Patients with a neurologic injury who develop the belief that known people are imposters (Capgras syndrome) or that strangers are actually loved ones in disguise (Fregoli syndrome) may have a single ...

Add Yahoo as a preferred source to see more of our stories on Google. Artificial intelligence (AI) could help detect abnormalities in the brain linked to epilepsy that can sometimes be missed by ...

Overall survival in metastatic HER2-positive breast cancer varied by location of brain lesions. Patients with central nervous system (CNS)-only disease had a higher risk of CNS-related death, despite ...

Brain lesions — areas of brain tissue that show damage from injury or disease — are the biomarker most widely used to determine multiple sclerosis disease progression. But an innovative new study led ...

In cancer patients with brain metastases and type 2 diabetes, those using GLP-1 drugs had a 37% lower risk of death over 3 years. Significant mortality benefits were linked to semaglutide and ...